Erythropoietin and the vascular wall: The controversy continues
Nutrition, Metabolism & Cardiovascular Diseases, 06/22/2012
Jelkmann W et al. – The enthusiastic reports of the nonhematopoietic cytoprotective potential of erythropoietin (EPO) and its derivatives in the cardiovascular system have not yet been confirmed in placebo–controlled clinical trials.



